Description
Acetohexamide, a sulfonylurea derivative, is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2, particularly in people whose diabetes cannot be controlled by diet alone. It is a hyopglycemic agent with moderate uricosuric activity. It stimulates the pancreas to secrete insulin and is used as an oral hypoglycemic agent. It was developed by Eli Lilly and Company and has been listed